Freeze-dried Oncaspar gets EU green light
European regulators have approved a new, freeze-dried formulation of Shire’s leukaemia therapy Oncaspar.
Read More
Tag: Oncaspar
- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
